PMID: 2508226Aug 1, 1989Paper

Teichoic acid antibody assay in infections of the bones and joints caused by Staphylococcus aureus

Der Unfallchirurg
A Groll, P M Shah

Abstract

For detecting antibodies against the teichoic acids of Staphylococcus aureus (SA), a commercially available Ouchterlony double-diffusion procedure kit was chosen. Thirteen of 26 patients with chronic SA osteomyelitis, 2 of 2 with SA spondylitis and 5 of 6 with arthritis had a positive assay (58%) in contrast to 8 of 24 patients of the control groups (33%). High titers correlated well with the extent and duration of antigen presentation in the bloodstream for cells of representing the specific immunity. Localized infections with minor antigenemia elicited a detectable but weak antibody response.

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.